His main research concerns Pulmonary hypertension, Internal medicine, Cardiology, Respiratory disease and Anesthesia. His work deals with themes such as Hemodynamics, Vascular resistance, Blood pressure, Sildenafil and Pulmonary artery, which intersect with Pulmonary hypertension. His research combines Surgery and Internal medicine.
His Cardiology study combines topics from a wide range of disciplines, such as Expert consensus and Guideline. His research in Respiratory disease intersects with topics in Artery, Circulatory system, Cardiac index and Chemotherapy. His Anesthesia research is multidisciplinary, incorporating elements of Nitric oxide and Iloprost.
Horst Olschewski mainly focuses on Internal medicine, Pulmonary hypertension, Cardiology, Hemodynamics and Anesthesia. In general Internal medicine, his work in Lung is often linked to In patient linking many areas of study. His work carried out in the field of Pulmonary hypertension brings together such families of science as Respiratory disease, Iloprost, Vascular resistance, Pulmonary artery and Vasodilation.
His Vasodilation research is multidisciplinary, relying on both Pharmacology and Prostacyclin. His Cardiology research includes themes of Vascular disease, Blood pressure and Hypoxia. The Anesthesia study combines topics in areas such as Sildenafil and Treprostinil.
Horst Olschewski mostly deals with Internal medicine, Cardiology, Pulmonary hypertension, In patient and Lung. His Internal medicine study frequently draws parallels with other fields, such as Oncology. His Cardiology study integrates concerns from other disciplines, such as Hazard ratio, Nintedanib and DLCO.
His Nintedanib course of study focuses on Sildenafil and Brain natriuretic peptide. The study incorporates disciplines such as Intensive care medicine, Magnetic resonance imaging, Pulmonary artery, Hemodynamics and Vasodilation in addition to Pulmonary hypertension. His Lung research integrates issues from Cancer research, Adverse effect and Pulmonary function testing.
His scientific interests lie mostly in Pulmonary hypertension, Internal medicine, Intensive care medicine, Cancer research and Lung. His Pulmonary hypertension study combines topics in areas such as Rehabilitation, Physical therapy, Training, Hypoxia and MEDLINE. His Internal medicine research incorporates elements of Bone morphogenetic protein, Oncology and Cardiology.
His study on Cardiology is mostly dedicated to connecting different topics, such as Vital capacity. The concepts of his Intensive care medicine study are interwoven with issues in Hemodynamics, ARDS and Community-acquired pneumonia, Pneumonia. His studies in Cancer research integrate themes in fields like Cancer cell, Glycolysis, Phosphoenolpyruvate carboxykinase, Pulmonary fibrosis and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau;Michael A Gatzoulis;Ian Adatia;David Celermajer.
Journal of the American College of Cardiology (2009)
Inhaled iloprost for severe pulmonary hypertension.
Horst Olschewski;Gerald Simonneau;Nazzareno Galiè;Timothy Higenbottam.
The New England Journal of Medicine (2002)
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.
Nazzareno Galiè;Adam Torbicki;Robyn Barst;Philippe Dartevelle.
European Heart Journal (2004)
Diagnosis and Assessment of Pulmonary Arterial Hypertension
David B. Badesch;Hunter C. Champion;Miguel Angel Gomez Sanchez;Marius M. Hoeper.
Journal of the American College of Cardiology (2009)
Diagnosis and differential assessment of pulmonary arterial hypertension
Robyn J Barst;Michael McGoon;Adam Torbicki;Olivier Sitbon.
Journal of the American College of Cardiology (2004)
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galiè;Horst Olschewski;Ronald J. Oudiz;Fernando Torres.
Circulation (2008)
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly.
The Lancet (2002)
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review
G Kovacs;A Berghold;S Scheidl;H Olschewski.
European Respiratory Journal (2009)
Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.
Richard Schulz;Siamak Mahmoudi;Katja Hattar;Ulf Sibelius.
American Journal of Respiratory and Critical Care Medicine (2000)
Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension
Derliz Mereles;Nicola Ehlken;Sandra Kreuscher;Stefanie Ghofrani.
Circulation (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Giessen
University of Giessen
University of Toronto
Hannover Medical School
University of Giessen
University of Giessen
Medical University of Vienna
University of Giessen
University of California, San Diego
University of Paris-Saclay
Pennsylvania State University
University of Southampton
University of Chicago
Chang Gung University
Ludwig-Maximilians-Universität München
University of Technology Sydney
Huazhong University of Science and Technology
Université Paris Cité
National Renewable Energy Laboratory
Spanish National Research Council
Institut de Biologie Moléculaire des Plantes
University of Tokyo
East Carolina University
University of Edinburgh
Geophysical Fluid Dynamics Laboratory
Mayo Clinic